Home » Bioluminescence helps researchers develop cancer drugs for brain – Scope

Bioluminescence helps researchers develop cancer drugs for brain – Scope

by admin
AdobeStock 319673883 scaled


30-second summary:
Bioluminescence is assisting scientists in the development of drugs for treating brain cancer. Researchers are using a luciferase gene, which emits light, to visualize the treatment’s effectiveness when administered to live animals. This innovative technique allows researchers to monitor tumors’ growth and determine drug dosage. In addition, scientists are optimistic that this approach will reduce the time and cost of drug development. Brain cancer is a rare but deadly disease, and drug development is still in its early stages. This promising method may bring a new wave of treatments to cancer patients.

Click here for the full news:
scopeblog.stanford.edu

Trouble reading news?
Please right-click with the mouse (if you use touchscreen: long press ) on the link above, then select “Open in New Tab”.

You may also like

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

Our Company

Megatrend Monitor empowers future-forward thinkers with cutting-edge insights and news on global megatrends. 

Newsletter

Register for our newsletter and be the first to know about game-changing megatrends!

Copyright © 2024 MegatrendMonitor.com. All rights reserved.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

error: Please respect our TERMS OF USE POLICY and refrain from copying or redistributing our content without our permission.